MORN.NASDAQMorningstar, INC

Form 4: Morningstar Executive Chairman Joseph Mansueto Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Joseph Mansueto, Executive Chairman of Morningstar, Inc., sold shares of common stock on February 23 and 26, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Joseph D. Mansueto, Executive Chairman of Morningstar, Inc., reported the sale of common stock on February 23 and 26, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on February 28, 2023.
  • On February 23, 2024, a total of 13,344 shares were sold at prices ranging from $282.10 to $301.84.
  • On February 26, 2024, a total of 6,198 shares were sold at prices ranging from $297.71 to $300.53.
  • Following these transactions, Mansueto directly owns 10,852,973 shares of Morningstar common stock.
  • Mansueto also indirectly owns 4,752,663 shares through grantor retained annuity trusts and 150,000 shares through trusts for the benefit of his children.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing share sales by an executive, which is neither inherently positive nor negative. The use of a 10b5-1 plan suggests the sales were pre-planned and routine.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The use of a 10b5-1 plan indicates that these sales were pre-planned and not based on any inside information at the time of the transactions.

Comparison to Industry Standards

  • Executive share sales are common and are often part of personal financial planning.
  • The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
  • Comparable companies such as FactSet, MSCI, and S&P Global also see regular Form 4 filings from their executives.

Stakeholder Impact

  • The share sales may have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
  • The sales do not appear to have any direct impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
02/28/2023Date of adoption of the Rule 10b5-1 trading plan
02/23/2024Date of first reported transaction (share sales)
02/26/2024Date of second reported transaction (share sales)
02/27/2024Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.